A dose-escalating study of the safety and pharmacokinetics of GSK679586A in healthy volunteers and mild asthmatics.
Phase of Trial: Phase I
Latest Information Update: 23 May 2012
At a glance
- Drugs GSK 679586A (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 18 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 05 Jan 2007 New trial record.